NSUP
UTHR icon

NLB Skladi upravljanje premozenja’s United Therapeutics UTHR Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Sell
4,110
-700
-15% -$394K 0.08% 163
2026
Q1 		$2.85M Sell
4,810
-675
-12% -$336K 0.14% 129
2025
Q4 		$2.67M Buy
+5,485
New +$2.55M 0.12% 137

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

NLB Skladi upravljanje premozenja's UTHR Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja reduced its United Therapeutics (UTHR) stake by 15% in Q2 2026, selling an estimated $394K and leaving 4,110 shares worth $2.23M. The position accounts for 0.08% of the portfolio, ranked #163.

NLB Skladi upravljanje premozenja first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.85M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 4,110 shares of United Therapeutics worth $2.23M as of Q2 2026.
  • NLB Skladi upravljanje premozenja sold 700 United Therapeutics shares in Q2 2026, an estimated $394K.
  • United Therapeutics made up 0.08% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #163 holding.
  • NLB Skladi upravljanje premozenja first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • NLB Skladi upravljanje premozenja's United Therapeutics position peaked at $2.85M in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.